Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application

被引：36

作者：

Jiang, Peng ^{[1
]}

Dai, Weixing ^{[1
]}

Yan, Shikai ^{[2
]}

Chen, Zhongliang ^{[3
]}

Xu, Ruilin ^{[3
]}

Ding, Jianmi ^{[3
]}

Xiang, Li ^{[1
]}

Wang, Shuping ^{[1
]}

Liu, Runhui ^{[1
]}

Zhang, Weidong ^{[1
,2
]}

机构：

[1] Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China

[2] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China

[3] Shanghai Hutchison Pharmaceut Co, Shanghai 200331, Peoples R China

来源：

MOLECULAR BIOSYSTEMS | 2011年 / 7卷 / 03期

关键词：

FLIGHT MASS-SPECTROMETRY; PURINE METABOLISM; PERFORMANCE; ISCHEMIA; GLUTAMATE; HEART; ASSOCIATION; MECHANISM; PHOSPHATE; CITRATE;

D O I：

10.1039/c0mb00110d

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A metabolomic method using reversed-phase liquid chromatography/quadrupole time-of-flight mass spectrometry (LC-Q-TOF-MS) was developed to obtain a systematic view of the development and progression of myocardial infarction (MI). By combining with partial least squares discriminant analysis (PLS-DA), 16 biomarkers in rat urine were identified and eight of them were related to the pathway of energy metabolism. Among the regulated pathways, the citric acid cycle related network was acutely perturbed. The metabolomic results not only supplied a systematic view of the development and progression of MI but also provided the theoretical basis for the prevention or treatment of MI. The developed method was also used to analyze the therapeutic effects of a traditional Chinese medicine (TCM) named Shexiang Baoxin Pill (SBP), a widely used anti-MI medicine in clinics. The results showed that SBP administration could provide satisfactory effects on MI through partially regulating the perturbed pathway of energy metabolism.

引用

页码：824 / 831

页数：8

共 31 条

[1] Apple FS, 2001, CLIN CHEM, V47, P377
[2] Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Bogdanov, Mikhail
Matson, Wayne R.
Wang, Lei
Matson, Theodore
Saunders-Pullman, Rachel
Bressman, Susan S.
Beal, M. Flint
[J]. BRAIN, 2008, 131 : 389 - 396
[3] PROLONGED DERANGEMENTS OF CANINE MYOCARDIAL PURINE METABOLISM AFTER A BRIEF CORONARY-ARTERY OCCLUSION NOT ASSOCIATED WITH ANATOMIC EVIDENCE OF NECROSIS
DEBOER, LWV
INGWALL, JS
KLONER, RA
BRAUNWALD, E
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (09): : 5471 - 5475
[4] FELICITAS B, 2005, J BIOL CHEM, V280, P36334
[5] RELATION BETWEEN CORONARY-ARTERY STENOSIS AND MYOCARDIAL PURINE METABOLISM, HISTOLOGY AND REGIONAL FUNCTION IN HUMANS
FLAMENG, W
VANHAECKE, J
VANBELLE, H
BORGERS, M
DEBEER, L
MINTEN, J
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (06) : 1235 - 1242
[6] High temperature-ultra performance liquid chromatography-mass spectrometry for the metabonomic analysis of Zucker rat urine
Gika, Helen G.
Theodoridis, Georgios
Extance, Jon
Edge, Anthony M.
Wilson, Ian D.
[J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 871 (02): : 279 - 287
[7] GORDON A, 1995, CARDIOVASC RES, V30, P413, DOI 10.1016/0008-6363(95)00062-3
[8] MITOCHONDRIAL PYRUVATE CARRIER - KINETICS AND SPECIFICITY FOR SUBSTRATES AND INHIBITORS
HALESTRAP, AP
[J]. BIOCHEMICAL JOURNAL, 1975, 148 (01) : 85 - 96
[9] Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry
Lv, Yonghai
Liu, Xinru
Yan, Shikai
Liang, Xu
Yang, Yun
Dai, Weixing
Zhang, Weidong
[J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 52 (01) : 129 - 135
[10] Close association between the reduction in myocardial energy metabolism and infarct size: Dose-response assessment of cyclosporine
Niemann, CU
Saeed, M
Akbari, H
Jacobsen, W
Benet, LZ
Christians, U
Serkova, N
[J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (03) : 1123 - 1128

← 1 2 3 4 →